BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15848274)

  • 21. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
    Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
    J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2041-8. PubMed ID: 9267005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
    He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
    J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
    Slike BM; Creegan M; Marovich M; Ngauy V
    PLoS One; 2017; 12(1):e0169247. PubMed ID: 28046039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity from smallpox vaccine persists for decades: a longitudinal study.
    Taub DD; Ershler WB; Janowski M; Artz A; Key ML; McKelvey J; Muller D; Moss B; Ferrucci L; Duffey PL; Longo DL
    Am J Med; 2008 Dec; 121(12):1058-64. PubMed ID: 19028201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
    Law M; Smith GL
    Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
    Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological Immunity to Smallpox in New South Wales, Australia.
    Costantino V; Trent MJ; Sullivan JS; Kunasekaran MP; Gray R; MacIntyre R
    Viruses; 2020 May; 12(5):. PubMed ID: 32443405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.
    Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW
    J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis.
    Eto A; Fujita M; Nishiyama Y; Saito T; Molina DM; Morikawa S; Saijo M; Shinmura Y; Kanatani Y
    Vaccine; 2019 Oct; 37(44):6588-6593. PubMed ID: 31540810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.
    Benhnia MR; McCausland MM; Su HP; Singh K; Hoffmann J; Davies DH; Felgner PL; Head S; Sette A; Garboczi DN; Crotty S
    J Virol; 2008 Apr; 82(7):3751-68. PubMed ID: 18234801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.
    Duke-Cohan JS; Wollenick K; Witten EA; Seaman MS; Baden LR; Dolin R; Reinherz EL
    Vaccine; 2009 Feb; 27(8):1154-65. PubMed ID: 19146908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
    Hughes CM; Newman FK; Davidson WB; Olson VA; Smith SK; Holman RC; Yan L; Frey SE; Belshe RB; Karem KL; Damon IK
    Clin Vaccine Immunol; 2012 Jul; 19(7):1116-8. PubMed ID: 22593237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
    Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N
    JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
    Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
    J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
    Liu Q; Huang W; Nie J; Zhu R; Gao D; Song A; Meng S; Xu X; Wang Y
    PLoS One; 2012; 7(3):e33392. PubMed ID: 22438922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
    Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
    PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.
    Benhnia MR; Maybeno M; Blum D; Aguilar-Sino R; Matho M; Meng X; Head S; Felgner PL; Zajonc DM; Koriazova L; Kato S; Burton DR; Xiang Y; Crowe JE; Peters B; Crotty S
    J Virol; 2013 Feb; 87(3):1569-85. PubMed ID: 23152530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A; Baljer G; Wagner C; Sailer J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.